Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
NCT06964815 · Istituto Oncologico Veneto IRCCS
Silibinin as STAT3 inhibitor · Placebo
3 of 16 sites
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, BO · Not yet recruiting
- IRST Dino Amadori, Meldola, FC · Not yet recruiting